Share

Hungarian Research Could Revolutionize Thyroid Cancer Treatment


A multi-year study by Semmelweis University and Premier Med Institute of Health, Education and Research to develop a new minimally invasive treatment for certain thyroid tumors has been successfully completed. The incisionless procedure could revolutionize the treatment of thyroid cancer in Central and Eastern Europe.

As a result of the study, Hungary is the first country in the region to offer this technology without incision (open surgery), which not only provides patients with a faster and less risky cure, but also preserves thyroid function, Semmelweis University announced. In the statement, Pál Ákos Deák, Associate Professor and Chief of Interventional Radiology at Semmelweis University and Premier Med, said about the new method that

Hungary can play a leading role in medical innovation, especially in the field of minimally invasive cancer treatment.

Dr. Pál Ákos Deák presents an incisionless thyroid cancer operation at the Premier Med Institution on February 12, 2025. Photo: MTI/Balogh Zoltán

He pointed out that the heat treatment technology, radiofrequency ablation (RFA), was first and only in Central and Eastern Europe to be used by Premier Med in recent years for benign thyroid nodules and is now also being used successfully for malignant thyroid tumors. The technique involves using a thin needle to puncture the tumor in the thyroid gland, followed by ultrasound, heating the tissue and the heat generated destroys the abnormal cells without damaging the thyroid gland.

After the procedure, patients do not need hormone replacement therapy, complications are significantly reduced and recovery is much faster.

The professor also noted that the procedure minimizes the surgical burden, the risk of infection and leaves no scars. In addition, the treatment requires far fewer resources and financial outlay than the more typical surgical options in inpatient care, he explained.

Zsófia Riesz, director of strategy and communication at Premier Med, said the research, which cost almost 300 million forints (750,000 euros), was supported by the National Research, Development and Innovation Office (NKFI) with more than 167 million forints (415,000 euros).

Related article

Innovative Methods Help Treat Cancer Patients in Szeged

Innovative Methods Help Treat Cancer Patients in Szeged

Interventional oncology opens up new perspectives in the treatment of cancer.Continue reading

Via MTI, Featured image: MTI/Balogh Zoltán





Source link